loader2
Partner With Us

Oct 27, 2021


Category

Equity

AUM (Cr.)

5,474.07

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.88

Sharpe Ratio

18.81

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (G) -1.81 11.15 33.33 27.13 15.73 21.63
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS 2.04 23.98 61.07 22.76 15.08 18.26
Category Rank 10/6 10/6 8/6 7/6 7/6 6/6
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
DSP Natural Resources & New Energy Fund (G) 55.8740 1.68 95.44 22.00 16.68 734.60 0.00 500.00 invest
LIC MF Infrastructure Fund (IDCW) 22.1086 1.39 69.60 21.73 13.08 78.66 0.00 5,000.00 invest
LIC MF Infrastructure Fund (G) 22.1072 1.39 69.59 21.73 13.07 78.66 0.00 5,000.00 invest
SBI Technology Opportunities Fund (G) 153.6633 1.25 78.69 38.00 28.18 1,701.01 2.30 5,000.00 invest
SBI Magnum Equity ESG Fund (IDCW) 53.5107 -89.29 56.84 23.91 15.44 4,309.54 2.07 1,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Sep 30, 2021 621.95 11.36 3.05
Equity-Dr Reddy`s Labs Sep 30, 2021 512.47 9.36 8.94
Equity-Divi`s Lab. Sep 30, 2021 455.88 8.33 -19.89
Equity-Aurobindo Pharma Sep 30, 2021 398.64 7.28 21.80
Equity-Cipla Sep 30, 2021 393.42 7.19 3.77
Equity-Apollo Hospitals Sep 30, 2021 345.43 6.31 -9.82
Equity-Lupin Sep 30, 2021 295.00 5.39 -9.42
Equity-Gland Pharma Sep 30, 2021 284.45 5.20 -14.06
Equity-Abbott India Sep 30, 2021 264.00 4.82 20.51
Equity-Narayana Hrudaya Sep 30, 2021 247.42 4.52 -7.08

latest news

Nippon India Mutual Fund Announces Appointment of Key Personnel

Nippon India Mutual Fund has announced that Rishit Bipin Parikh has been ap...

Oct 14, 2021 13:37

Nippon India Balanced Advantage Fund Announces Dividend

Nippon India Mutual Fund has announced 12 October 2021 as the record date f...

Oct 07, 2021 12:17

Nippon India Fixed Horizon Fund - XLI - Series 8 change in benchmark

Nippon India Mutual Fund / Nippon Life India Asset Management Limited has d...

Sep 29, 2021 12:36

Nippon India MF Announces change in fund managers under its schemes

Nippon India Mutual Fund has announced the following change in the fund man...

Sep 25, 2021 10:47

Nippon India US Equity Opportunities Fund Announces change in exit load structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Sep 17, 2021 12:49

Nippon India Mutual Fund Announces change in Minimum Application Amount & Minimum Additional Investment under two schemes

Nippon India Mutual Fund has decided to revise Minimum Application Amount &...

Sep 17, 2021 12:33

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (G)
Contact Persone : Sailesh Raj Bhan
Registered Address : Reliance Center, 7th Floor SouthWing, Off Western ExpressHighway, Santacruz(E) Mumbai-400055
Telephone No : 022-43031000/1860 266 0111
Fax No. : 022-43037662
Email : customercare@nipponindiamf.com
Website : www.nipponindiamf.com
Open an Account

Sign Up for Free

+91

Please use the mobile no registered with Aadhaar.

OTP sent to +91 1234567890

Didn’t received OTP? Resend

00:30

iciciDirect-money-logo
iciciDirectMoney-App

Get Research Backed Recommendations.

Download The app now

or Scan below QR Code To download app

QRcode